HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ben Davidson Selected Research

Carcinoma (Carcinomatosis)

11/2021Splice-Variant Knock-Out of TGFβ Receptors Perturbates the Proteome of Ovarian Carcinoma Cells.
3/2021The phosphatase PTPN1/PTP1B is a candidate marker of better chemotherapy response in metastatic high-grade serous carcinoma.
1/2021Repurposing 18F-FMISO as a PET tracer for translational imaging of nitroreductase-based gene directed enzyme prodrug therapy.
12/2020The Biological Role of the Long Non-coding RNA LINK-A in Ovarian Carcinoma.
12/2020Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma.
11/2020Expression of palladin is associated with disease progression in metastatic high-grade serous carcinoma.
7/2020The Biological and Clinical Role of the Long Non-Coding RNA LOC642852 in Ovarian Carcinoma.
1/2020MGMT promoter methylation is a rare epigenetic change in malignant effusions.
9/2019Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer.
2/2019Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ben Davidson Research Topics

Disease

168Neoplasms (Cancer)
06/2022 - 01/2002
144Carcinoma (Carcinomatosis)
11/2021 - 01/2002
63Neoplasm Metastasis (Metastasis)
07/2021 - 01/2002
47Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 10/2003
28Malignant Mesothelioma
03/2021 - 01/2004
28Breast Neoplasms (Breast Cancer)
01/2020 - 01/2004
13Disease Progression
03/2016 - 10/2003
10Mesothelioma
01/2019 - 05/2007
9Adenocarcinoma
01/2021 - 11/2005
7Ovarian Epithelial Carcinoma
09/2017 - 05/2004
7Pleural Effusion (Pleural Effusions)
01/2015 - 08/2003
7Melanoma (Melanoma, Malignant)
02/2012 - 05/2004
6Endometrial Neoplasms (Endometrial Cancer)
05/2022 - 09/2008
6Sarcoma (Soft Tissue Sarcoma)
01/2019 - 03/2016
5Lymphatic Metastasis
08/2021 - 11/2004
5Leiomyosarcoma
01/2021 - 03/2016
5Carcinogenesis
03/2017 - 02/2006
4Aneuploidy (Aneuploid)
11/2010 - 01/2005
4Nevus (Nevi)
01/2010 - 09/2004
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 08/2010
3Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor)
01/2018 - 08/2016
3Chromosome Aberrations (Chromosome Abnormalities)
03/2017 - 08/2013
3Residual Neoplasm
05/2012 - 12/2011
2Pseudomyxoma Peritonei
10/2021 - 08/2010

Drug/Important Bio-Agent (IBA)

83Proteins (Proteins, Gene)FDA Link
05/2021 - 01/2002
53Messenger RNA (mRNA)IBA
05/2021 - 01/2002
29Biological ProductsIBA
11/2021 - 05/2002
22Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2008
16MicroRNAs (MicroRNA)IBA
01/2019 - 06/2008
14DNA (Deoxyribonucleic Acid)IBA
05/2021 - 06/2004
13Cadherins (E-Cadherin)IBA
01/2019 - 07/2002
10Paclitaxel (Taxol)FDA LinkGeneric
09/2019 - 07/2004
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 01/2002
9RNA (Ribonucleic Acid)IBA
01/2019 - 08/2013
9Transcription Factors (Transcription Factor)IBA
02/2015 - 04/2003
8EnzymesIBA
10/2020 - 02/2007
8PlatinumIBA
10/2020 - 07/2004
8Phosphotransferases (Kinase)IBA
01/2019 - 01/2003
8Pharmaceutical PreparationsIBA
09/2017 - 12/2003
8Carboplatin (JM8)FDA LinkGeneric
09/2017 - 01/2010
8Mitogen-Activated Protein KinasesIBA
01/2016 - 01/2003
8IntegrinsIBA
05/2008 - 01/2003
8Matrix Metalloproteinases (MMPs)IBA
02/2007 - 02/2002
7RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2018 - 04/2005
7Protein Isoforms (Isoforms)IBA
01/2017 - 06/2005
6Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2021 - 03/2003
6Peptide Hydrolases (Proteases)FDA Link
01/2014 - 01/2004
6Small Interfering RNA (siRNA)IBA
07/2013 - 01/2005
6Laminin ReceptorsIBA
02/2006 - 01/2003
5SurvivinIBA
01/2016 - 01/2007
5Proto-Oncogene Proteins c-etsIBA
04/2012 - 03/2003
5Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
02/2007 - 01/2004
5Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
01/2007 - 06/2003
5Interleukin-8 (Interleukin 8)IBA
11/2005 - 01/2002
4Long Noncoding RNAIBA
12/2020 - 10/2015
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019 - 05/2004
4AntibodiesIBA
01/2018 - 09/2007
4VimentinIBA
09/2017 - 03/2010
4Laminin (Merosin)IBA
02/2011 - 05/2004
4NF-kappa B (NF-kB)IBA
07/2010 - 06/2009
4JNK Mitogen-Activated Protein KinasesIBA
01/2007 - 01/2003
4Nerve Growth Factor (NGF)IBA
01/2007 - 06/2003
3ParaffinIBA
05/2022 - 07/2007
3ProteomeIBA
11/2021 - 06/2010
3Transforming Growth Factors (Transforming Growth Factor)IBA
11/2021 - 06/2011
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2021 - 10/2005
3MOC31PE immunotoxinIBA
01/2021 - 07/2017
3Epithelial Cell Adhesion MoleculeIBA
09/2017 - 01/2008
3Estrogen ReceptorsIBA
04/2016 - 11/2004
3Progesterone Receptors (Progesterone Receptor)IBA
04/2016 - 11/2004
3Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2016 - 05/2009
3Cisplatin (Platino)FDA LinkGeneric
10/2015 - 11/2007
3AntigensIBA
02/2012 - 07/2006
3EndoglinIBA
06/2011 - 11/2008
3Leukocyte L1 Antigen Complex (Calgranulin)IBA
12/2010 - 04/2008
3Claudin-1IBA
08/2010 - 06/2007
3Claudin-3IBA
08/2010 - 06/2007
3ImmunosorbentsIBA
04/2009 - 04/2008
3Chemokine ReceptorsIBA
09/2008 - 03/2006
3kallikrein 4IBA
02/2007 - 07/2004
3heparanaseIBA
02/2007 - 01/2004
3Glycerol (Glycerine)FDA LinkGeneric
01/2007 - 01/2003
3trkA ReceptorIBA
01/2007 - 06/2003
3HLA-G Antigens (HLA G)IBA
07/2006 - 01/2005
3Integrin alpha6IBA
02/2006 - 01/2003
3Integrin alphaVIBA
11/2005 - 03/2003
3Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
06/2003 - 01/2002
3Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
04/2003 - 01/2003
3Metalloproteases (Metalloproteinases)IBA
01/2003 - 02/2002
2Formaldehyde (Formol)FDA Link
05/2022 - 07/2007
2Folic Acid (Vitamin M)FDA LinkGeneric
12/2021 - 10/2009
2Peptides (Polypeptides)IBA
10/2021 - 07/2008

Therapy/Procedure

49Drug Therapy (Chemotherapy)
03/2021 - 01/2003
21Therapeutics
07/2021 - 11/2007
5Neoadjuvant Therapy
08/2015 - 05/2012
3Cytoreduction Surgical Procedures
06/2020 - 12/2011
2Immunotherapy
06/2022 - 05/2022
2Hysterectomy
08/2021 - 11/2010
2Precision Medicine
07/2021 - 01/2019
2Computer-Assisted Surgery (Image Guided Surgery)
07/2021 - 06/2020